drugset / Trial / NCT04685395

Comparative Efficacy of Rebamipide Gargle And Benzydamine HCL Gargle in Prevention and Management of Chemo- and Radio-therapy-induced Oral Mucositis

NCT04685395

Phase 3 Unknown 100 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

evaluate preventive and therapeutic effects of Rebamipide gargle on reducing incidence of oral mucositis in comparison with benzydamine HCL mouthwash.

Timeline

Start
2019-12-26
Primary completion
2021-06-30
Completion
2021-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzydamine Unknown 5 ml Other
Comparator Rebamipide Small molecule 5 ml Other

Indications